27
May
Martin Endjala The Central Procurement Board of Namibia (CPBN) is busy studying the High Court ruling last week, which nullified the CPBN decision to award a N$1.3 billion pharmaceutical supply tender to Cospharm Investment Pty Ltd. CPBN spokesperson Johanna Kambala said this in response to questions about whether the board will re-run the tender process or possibly re-award it. “Kindly be informed that CPBN is busy studying the ruling and thus will only revert once consultations have taken place,” said Kambala. Businessman Shapwa Kanyama's Africure Pharmaceutical took Cospharm, the CPBN, and other bidders to court last year. Cospharm was to…
